Home » Chinese Healthcare Investors »


|| Chinese investors acquired stake at Israeli biotech firm for $3 million

GuangxiWuzhou-IL.jpg
Guangxi Wuzhou Zhongheng Group, a Chinese investment holdings company, through its subsidiary has invested $3 million in Israeli biotechnology firm Integra Holdings.

Integra Holdings, founded in 2012, has a portfolio of companies operating in a variety of therapeutic areas such as oncology, Alzheimer's disease and infectious diseases. Integra Holdings has raised a total of $12 million to date.

Guangxi Wuzhou Zongheng Group is listed in the Chinese Investors Directory with the code XJO31

More details follows



Previous Post: Chinese investors acquired Melbourne Prince Hotel for $45 million
Next Post: CITIC Securities going to buy 60% of issued share from the retail Forex broker KVB Kunlun

More from Chinese Healthcare Investors ...


  Chinese firm invested $12 million in UK company Blueberry Therapeutics

  Chinese investors acquired SciClone Pharmaceuticals for $605 million

  Chinese firm acquired Canada Iovate Health for $730 million

  Chinese investors acquired Australian vitamin maker Vitaco for $239 million

  Chinese investors of ORI Capital invested $18 million in Boston firm Pillar Biosciences

  Chinese investors of Citic acquired stake at Singapore medical firm for $817 million

  Chinese Hepalink acquired US Cytovance Biologics for $205 million

  Chinese investors acquired stake at Israeli biotech firm for $3 million

  Chinese investors of LongTec invested $10 million in RealView Imaging

  Chinese Decheng Capital and consortium invested $120 million in California genetics firm





| About Us

Rubenstein
SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.



|Subscribe to mailing list

Enter your email address:



Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2021     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on LinkedIn